Page last updated: 2024-08-23

cabergoline and Adenoma, Acidophil

cabergoline has been researched along with Adenoma, Acidophil in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bianchi, F; Culler, MD; Dadati, P; Ferone, D; Jaquet, P; Minuto, F; Ravetti, JL; Rebora, A; Resmini, E; Saveanu, A; Spaziante, R; Zona, G1
Herman-Bonert, V; Kovacs, K; Maheshwari, HG; Melmed, S; Prezant, TR; Shahinian, H1

Other Studies

2 other study(ies) available for cabergoline and Adenoma, Acidophil

ArticleYear
Rapid pituitary tumor shrinkage with dissociation between antiproliferative and antisecretory effects of a long-acting octreotide in an acromegalic patient.
    The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:5

    Topics: Acromegaly; Adenoma, Acidophil; Adult; Cabergoline; Cell Proliferation; Cells, Cultured; Delayed-Action Preparations; Ergolines; Human Growth Hormone; Humans; Immunohistochemistry; Insulin-Like Growth Factor I; Magnetic Resonance Imaging; Male; Microscopy, Electron; Octreotide; Pituitary Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Somatostatin; Thymidine

2007
Long-acting peptidomimergic control of gigantism caused by pituitary acidophilic stem cell adenoma.
    The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:9

    Topics: Adenoma, Acidophil; Adolescent; Antineoplastic Agents, Hormonal; Cabergoline; Delayed-Action Preparations; Dopamine Agonists; Ergolines; Female; Gigantism; Hormones; Humans; Magnetic Resonance Imaging; Octreotide; Pituitary Neoplasms; Receptors, Dopamine D2; Receptors, Somatostatin; Reverse Transcriptase Polymerase Chain Reaction; Stem Cells

2000